Larimar Therapeutics, Inc. (LRMR) vs Zentalis Pharmaceuticals, Inc. (ZNTL)
- Larimar Therapeutics, Inc. LRMR 1.98 −0.50%
- Zentalis Pharmaceuticals, Inc. ZNTL 2.13 −4.91%
Larimar Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Larimar Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($212.1M and $206.7M). Across the 8 metrics below, Zentalis Pharmaceuticals, Inc. leads on 6 and Larimar Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | LRMR | ZNTL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (138.41%) | (66.75%) | (56.36%) |
| Return on assets | (108.53%) | (49.22%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack